RedHill Biopharma (RDHL) Long-Term Investments (2025)
RedHill Biopharma (RDHL) posted quarterly Long-Term Investments of $12.0 million for Q4 2025.
RedHill Biopharma (RDHL) Long-Term Investments (2025) Analysis & Trends
RedHill Biopharma (RDHL) has reported Long-Term Investments for 1 consecutive years, with $12.0 million the latest figure, recorded in Q4 2025.
- In Q4 2025, Long-Term Investments changed N/A year-over-year to $12.0 million; the TTM figure through Dec 2025 stood at $12.0 million (changed N/A YoY), while the FY2025 annual figure was $12.0 million, changed N/A from the prior year.
- Long-Term Investments steadied at $12.0 million in Q4 2025 per RDHL's latest filing.
- Across five years, Long-Term Investments topped out at $12.0 million in Q4 2025 and bottomed at $12.0 million in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Long-Term Investments (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.91 Bn | 42.95 Bn | - | 92.58 Mn |
| 2 | Teva Pharmaceutical Industries | 42.98 Bn | 39.32 Bn | 2.15 Bn | - |
| 3 | Zoetis | 31.53 Bn | 29.86 Bn | 1.05 Bn | - |
| 4 | Takeda Pharmaceutical | 28.61 Bn | 22.81 Bn | 5.10 Bn | 63.23 Mn |
| 5 | United Therapeutics | 22.16 Bn | 19.49 Bn | 683.80 Mn | 1.14 Bn |
| 6 | Viatris | 18.74 Bn | 17.85 Bn | 1.46 Bn | - |
| 7 | Neurocrine Biosciences | 15.51 Bn | 15.12 Bn | 935.80 Mn | 149.10 Mn |
| 8 | Elanco Animal Health | 11.76 Bn | 11.23 Bn | 798.00 Mn | - |
| 9 | Dr Reddys Laboratories | 10.12 Bn | 9.95 Bn | - | 60.00 Mn |
| 10 | RedHill Biopharma | 2.05 Bn | 2.05 Bn | - | 12.05 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 12.05 Mn |